The differences remained significant when an FDR correction was applied, i.e., a decrease in the level of expression of CA9, NDUFA4L2, EGLN3, BHLHE41, VWF, and ANGPTL4 is a factor in the unfavorable prognosis of ccRCC. This evidence concerns the gene EGLN3 and nonpapillary renal cell carcinoma.